People: Transition Therapeutics Inc (TTH.TO)
25 Nov 2014
Mr. Carl Damiani is Chief Operating Officer, Vice President - Business Development of Transition Therapeutics Inc. Mr. Damiani is a key member of the Company's management team and is responsible for a broad range of activities, including licensing and intellectual property strategies. Prior to joining Transition, Mr. Damiani led multiple successful start-up businesses in the biotech and services industries.
|Total Annual Compensation, CAD||Long-Term Incentive Plans, CAD||All Other, CAD||Fiscal Year Total, CAD|